These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18991046)

  • 1. Intravitreal injection of bevacizumab to treat neovascular glaucoma.
    Kubota T; Aoki R; Harada Y; Tou N; Tawara A
    Jpn J Ophthalmol; 2008; 52(5):410-412. PubMed ID: 18991046
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
    Vatavuk Z; Bencic G; Mandic Z
    Eur J Ophthalmol; 2007; 17(2):269-71. PubMed ID: 17415704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S; Hendi K; Pakravan M
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
    Chilov MN; Grigg JR; Playfair TJ
    Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
    Nakashima C; Keino H; Watanabe T; Taki W; Okada AA
    Jpn J Ophthalmol; 2011 Jan; 55(1):80-1. PubMed ID: 21331703
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY; Schuman JS; Noecker RJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
    Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
    Eur J Ophthalmol; 2009; 19(4):607-12. PubMed ID: 19551676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
    Fong AW; Lee GA; O'Rourke P; Thomas R
    Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
    Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy.
    Bianciotto C; Shields CL; Kang B; Shields JA
    Arch Ophthalmol; 2008 Apr; 126(4):578-9. PubMed ID: 18413538
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.